-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's After-Market Session
Share
Listen to the news

Gainers

  • XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 7.8% to $1.52 during Friday's after-market session. The market value of their outstanding shares is at $3.3 million.
  • 20/20 Biolabs (NASDAQ:AIDX) shares increased by 6.66% to $0.4. The company's market cap stands at $4.8 million.
  • RenovoRx (NASDAQ:RNXT) stock increased by 6.25% to $1.36. The market value of their outstanding shares is at $60.0 million.
  • Zhengye Biotechnology (NASDAQ:ZYBT) stock rose 5.78% to $1.83. The market value of their outstanding shares is at $54.4 million.
  • Solid Biosciences (NASDAQ:SLDB) shares moved upwards by 5.24% to $7.23. The company's market cap stands at $731.2 million.
  • Oragenics (AMEX:OGEN) stock increased by 5.21% to $0.48. The company's market cap stands at $2.0 million.

Losers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock declined by 15.3% to $0.13 during Friday's after-market session.
  • Pomdoctor (NASDAQ:POM) stock decreased by 13.03% to $0.65. The market value of their outstanding shares is at $7.3 million.
  • Akso Health (NASDAQ:AHG) stock declined by 11.72% to $1.13. The market value of their outstanding shares is at $626.0 million.
  • Processa Pharma (NASDAQ:PCSA) stock decreased by 11.0% to $1.35. The company's market cap stands at $3.7 million.
  • Estrella Immunopharma (NASDAQ:ESLA) shares fell 6.59% to $0.38. The company's market cap stands at $18.1 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) stock fell 5.83% to $0.74. The market value of their outstanding shares is at $1.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending